Mercatus Capital leads angel investment in uber Diagnostics

Company to use funds to complete tests of handheld ECG machine

T E Narasimhan Chennai
Last Updated : Sep 08 2015 | 10:42 AM IST
Mercatus Capital Pte Ltd led angel investment in uber Diagnostics in a deal which saw investments from angel investors based in Netherlands, USA and Singapore. 

Quantum of the investment was not disclosed.

The investment enables uber Diagnostics to complete final tests of Cardiotrack, a diagnostic handheld ECG machine that will help in early detection and treatment of cardiovascular diseases.

Ravi Govindan, chairman and founder of Mercatus Capital said, “The socio economic costs of cardiovascular disease is staggering and growing exponentially. We are very pleased to be leading a broad-based group of angel investors in enabling the development of the ECG device and IoT platform. We believe that uber Diagnostics will disrupt the space for early detection and treatment of cardiovascular disease”.  

uber Diagnostics was founded by Ashim Roy, alumni of BITS Pilani and IIT-Delhi, and Avin Agarwal, an engineering graduate from VTU, Bangalore.

“By introducing Smart IoT sensors with handheld and mobile devices, the platform will connect patients, caregivers, doctors and specialists,” said co-founder and CEO Roy. 

Cardiotrack will allow general practitioners to undertake comprehensive cardiovascular diagnosis at the clinic, he said, adding that specialist support will be provided through cloud-based tele cardiology.

More From This Section

First Published: Sep 08 2015 | 10:34 AM IST

Next Story